dexelvucitabine has been researched along with HIV in 4 studies
*HIV: Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, SH; Cheng, YC; Doyle, TW; Dutschman, GE; Gullen, EA; King, I; Lin, S; Spinka, T | 1 |
| James, JS | 1 |
| Nelson, MR; Waters, L | 1 |
| Cheng, YC; Dutschman, GE; Gullen, E; Lin, TS; Liu, MC; Luo, MZ; Zhu, YL | 1 |
1 review(s) available for dexelvucitabine and HIV
| Article | Year |
|---|---|
New drugs.
Topics: Anti-HIV Agents; Benzophenones; Cytidine Triphosphate; Darunavir; Deoxycytidine; Emtricitabine; HIV; HIV Fusion Inhibitors; HIV Reverse Transcriptase; Humans; Imidazoles; Nitriles; Protease Inhibitors; Pyridazines; Pyridines; Pyrimidines; Pyrones; Reverse Transcriptase Inhibitors; Sulfonamides; Sulfur Compounds; Zalcitabine | 2005 |
3 other study(ies) available for dexelvucitabine and HIV
| Article | Year |
|---|---|
Synthesis and comparative evaluation of two antiviral agents: beta-L-Fd4C and beta-D-Fd4C.
Topics: Animals; Antiviral Agents; Hepatitis B virus; HIV; Mice; Rats; Stereoisomerism; Zalcitabine | 1998 |
Antiretroviral pipeline: new-drug reports from retroviruses conference.
Topics: Anti-HIV Agents; CCR5 Receptor Antagonists; Cytidine Triphosphate; Drug Resistance, Viral; HIV; HIV Fusion Inhibitors; Membrane Fusion; Zalcitabine | 2004 |
Design and synthesis of 2',3'-dideoxy-2',3'-didehydro-beta-L-cytidine (beta-L-d4C) and 2',3'-dideoxy 2',3'-didehydro-beta-L-5-fluorocytidine (beta-L-Fd4C), two exceptionally potent inhibitors of human hepatitis B virus (HBV) and potent inhibitors of human
Topics: Antiviral Agents; Drug Design; Hepatitis B virus; HIV; Humans; Zalcitabine | 1996 |